Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma

Study Title
Efficacy of Inhaled Albuterol Spiromaxֲ® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
Teva Identifier
ABS-AS-304
ClinicalTrials.gov Identifier
NCT01747629
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Placebo MDPI | Drug: Albuterol MDPI
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations
respiratory-icon

Key Participation Requirements

Gender
Female, Male
Age group
Child, Adult, Older Adult
Age Range
12 Years and older
Trial Duration
12/01/2012 - 11/01/2013
Phase
Phase 3

Study Type

Interventional